These emerging therapies, including Rybelsus, belong to a class of drugs called GLP-1 mimics . Initially developed for managing high blood sugar, they function by helping the pancreas to release sufficient insulin production and limiting excessive sugar levels. Beyond diabetes, their ability to support weight management has resulted to significant